Furthermore, several studies reported that PD-L1-enriched TEVs promote cancer immune evasion by reducing the abundance of CD4 + T cells, suggesting a pivotal role of immune checkpoint protein-bearing TEVs in regulating CD4 + T cells [118–120]. This evidence concerns the gene CD4 and cancer.